These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6804679)

  • 41. Action of cholecystokinin and caerulein on the rabbit sphincter of Oddi.
    Sarles JC; Bidart JM; Devaux MA; Echinard C; Castagnini A
    Digestion; 1976; 14(5-6):415-23. PubMed ID: 976625
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The influence of tifluadom on cholecystokinin-induced antinociception.
    Gericke M; Morgenstern R; Ott T
    Eur J Pharmacol; 1990 May; 180(1):187-90. PubMed ID: 2365002
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence for an involvement of the brain cholecystokinin B receptor in anxiety.
    Singh L; Lewis AS; Field MJ; Hughes J; Woodruff GN
    Proc Natl Acad Sci U S A; 1991 Feb; 88(4):1130-3. PubMed ID: 1996314
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of cholecystokinin-like peptides on rearing activity and hexobarbital-induced sleep.
    Zetler G
    Eur J Pharmacol; 1980 Aug; 66(1):137-9. PubMed ID: 6250861
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antagonism by thyrotropin-releasing hormone (TRH) of pentobarbital-induced hypothermia in rats with brain lesions.
    Ishikawa K; Suzuki M
    Experientia; 1986 Sep; 42(9):1029-31. PubMed ID: 3093262
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of the action of prostaglandin with endotoxin on thermoregulatory response thresholds.
    Hashimoto M; Nagai M; Iriki M
    Pflugers Arch; 1985 Sep; 405(1):1-4. PubMed ID: 3903650
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of intraventricular administration of cholecystokinin octapeptide sulfate ester and unsulfated cholecystokinin octapeptide on active avoidance and conditioned feeding behaviour of rats.
    Fekete M; Szabó A; Balázs M; Penke B; Telegdy G
    Acta Physiol Acad Sci Hung; 1981; 58(1):39-45. PubMed ID: 6282048
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The central thermoregulatory action of cholecystokinin-8 and prostaglandin E1].
    Szelényi Z; Székely M; Romanovskiĭ AA
    Fiziol Zh SSSR Im I M Sechenova; 1992 Apr; 78(4):94-101. PubMed ID: 1334868
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ethanol blocks the cold-induced increase in thyrotropin-releasing hormone mRNA in paraventricular nuclei but not the cold-induced increase in thyrotropin.
    Zoeller RT; Rudeen PK
    Brain Res Mol Brain Res; 1992 May; 13(4):321-30. PubMed ID: 1352612
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibitory effect of CCK-8 and ceruletide on glutamate-induced rises in intracellular free calcium concentrations in rat neuron cultures.
    Shinohara S; Katsuura G; Eigyo M; Shintaku H; Ibii N; Matsushita A
    Brain Res; 1992 Aug; 588(2):223-8. PubMed ID: 1356589
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cholecystokinin-octapeptide suppresses stress-induced eating by inducing hyperglycemia.
    Levine AS; Morley JE
    Regul Pept; 1981 Nov; 2(6):353-7. PubMed ID: 6272376
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of thyrotropin-releasing hormone (TRH) on the actions of pentobarbital and other centrally acting drugs.
    Breese GR; Cott JM; Cooper BR; Prange AJ; Lipton MA; Plotnikoff NP
    J Pharmacol Exp Ther; 1975 Apr; 193(1):11-22. PubMed ID: 805836
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Changes in motor activity and forebrain [propionyl-3H]propionylated-CCK-8 binding in mice after repeated administration of drugs affecting cholecystokinin receptors.
    Vasar E; Stephenson JD; Meldrum BS
    Eur J Pharmacol; 1991 Sep; 202(3):385-90. PubMed ID: 1748160
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Role of central alpha-adrenoreceptors in the mechanism of the hyperthermic action of prostaglandin E2].
    Gurin VN; Vismont FI; Tsariuk VV
    Farmakol Toksikol; 1984; 47(6):29-32. PubMed ID: 6097474
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interaction of cholecystokinin with vasoactive intestinal peptide in body shaking response to ice-water immersion in rats.
    Katsuura G; Yoshikawa K; Itoh S
    Neurosci Lett; 1983 Oct; 40(3):299-302. PubMed ID: 6646503
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunological blockade of endogenous thyrotropin-releasing hormone produces hypothermia in rats.
    Prasad C; Jacobs JJ; Wilber JF
    Brain Res; 1980 Jul; 193(2):580-3. PubMed ID: 6770963
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of cholecystokinin, caerulein and pentagastrin on electrical behavior of myenteric neurons.
    Nemeth PR; Zafirov DH; Wood JD
    Eur J Pharmacol; 1985 Oct; 116(3):263-9. PubMed ID: 4076339
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Satiety effects of cholecystokinin and caerulein in rabbits.
    Houpt TR; Anika SM; Wolff NC
    Am J Physiol; 1978 Jul; 235(1):R23-8. PubMed ID: 677336
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discrepancies between the doses of cholecystokinin or caerulein-stimulating exocrine and endocrine responses in perfused isolated rat pancreas.
    Otsuki M; Sakamoto C; Yuu H; Maeda M; Morita S; Ohki A; Kobayashi N; Terashi K; Okano K; Baba S
    J Clin Invest; 1979 Mar; 63(3):478-84. PubMed ID: 372241
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term effects of CCK-agonist and -antagonist on food intake and body weight in Zucker lean and obese rats.
    Meereis-Schwanke K; Klonowski-Stumpe H; Herberg L; Niederau C
    Peptides; 1998; 19(2):291-9. PubMed ID: 9493861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.